Evaluation of Novel Inhibitors of Tryptophan Dioxygenases for Enzyme and Species Selectivity Using Engineered Tumour Cell Lines Expressing Either Murine or Human IDO1 or TDO2.

Saved in:
Bibliographic Details
Title: Evaluation of Novel Inhibitors of Tryptophan Dioxygenases for Enzyme and Species Selectivity Using Engineered Tumour Cell Lines Expressing Either Murine or Human IDO1 or TDO2.
Authors: Tijono SM; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, School of Medicine, University of Auckland, Private 92019, Auckland 1142, New Zealand., Palmer BD; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, School of Medicine, University of Auckland, Private 92019, Auckland 1142, New Zealand., Tomek P; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, School of Medicine, University of Auckland, Private 92019, Auckland 1142, New Zealand., Flanagan JU; Department of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Sciences, School of Medicine, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand., Henare K; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, School of Medicine, University of Auckland, Private 92019, Auckland 1142, New Zealand., Gamage S; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, School of Medicine, University of Auckland, Private 92019, Auckland 1142, New Zealand., Braun L; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, School of Medicine, University of Auckland, Private 92019, Auckland 1142, New Zealand., Ching LM; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, School of Medicine, University of Auckland, Private 92019, Auckland 1142, New Zealand.
Source: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2022 Aug 31; Vol. 15 (9). Date of Electronic Publication: 2022 Aug 31.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1424-8247
DOI:10.3390/ph15091090